News

Sanofi’s Tzield gets expanded FDA approval for early-stage type 1 diabetes

Apr 29, 2026 | News, Regulatory

The treatment can be used to delay the onset of clinical type 1 diabetes

AstraZeneca reports positive phase 3 data for tozorakimab in COPD

Apr 28, 2026 | News, Research

COPD affects nearly 400 million people globally and is the third leading cause of death worldwide

Merck’s RSV antibody for infants approved by European Commission

Apr 28, 2026 | News, Regulatory

The approval offers a new RSV prevention option for infants

Eli Lilly to acquire Kelonia Therapeutics in deal worth up to $7bn

Apr 27, 2026 | News, Healthcare

The acquisition will help Lilly to expand its capabilities in cell and gene therapy

MHRA authorises Biogen’s higher-dose Spinraza for SMA treatment

Apr 27, 2026 | News, Regulatory

SMA is a rare genetic neuromuscular condition affecting around 1,600 people in the UK

J&J’s Icotyde approved by US FDA for plaque psoriasis

Apr 24, 2026 | News, Regulatory

Plaque psoriasis affects over 125 million people worldwide

AL-S Pharma release new data from AP-101 phase 2 trial for ALS

Apr 23, 2026 | News, Research

ALS is a progressive neurodegenerative disease that affects the motor neurons of the brain and spinal cord

Grifols share results identifying early signs of Parkinson’s disease

Apr 22, 2026 | News, Research

Parkinson’s disease affects over six million people globally

Shionogi starts phase 2 clinical trial for Pompe Disease

Apr 21, 2026 | News, Research

The rare disease affects around one in every 22,000 people worldwide

Astellas’ application to EMA validated for treatment of muscle-invasive bladder cancer

Apr 20, 2026 | News, Regulatory

Bladder cancer affects over 224,000 people annually in Europe, with over 30% of cases being muscle-invasive bladder cancer

Potential US-Iran peace deal to redraw market winners and losers

Apr 17, 2026 | News, Healthcare

With a 10-day ceasefire between Israel and Lebanon in effect, oil prices are retreating from recent highs

Sumitomo Pharma’s stem cell therapy for Parkinson’s given limited approval in Japan

Apr 17, 2026 | News, Regulatory

The company has been given manufacturing and marketing authorisation for the therapy

Sanofi’s Tzield gets expanded FDA approval for early-stage type 1 diabetes

AstraZeneca reports positive phase 3 data for tozorakimab in COPD

Merck’s RSV antibody for infants approved by European Commission

Eli Lilly to acquire Kelonia Therapeutics in deal worth up to $7bn

MHRA authorises Biogen’s higher-dose Spinraza for SMA treatment

J&J’s Icotyde approved by US FDA for plaque psoriasis

AL-S Pharma release new data from AP-101 phase 2 trial for ALS

Grifols share results identifying early signs of Parkinson’s disease

Shionogi starts phase 2 clinical trial for Pompe Disease

Astellas’ application to EMA validated for treatment of muscle-invasive bladder cancer

Potential US-Iran peace deal to redraw market winners and losers

Sumitomo Pharma’s stem cell therapy for Parkinson’s given limited approval in Japan

Latest content

Latest intelligence

Quick links